Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Melody Parker

BSc, MSc


Melody Parker is a bioinformatician in the Big Data Institute as part of the Lindgren group. Her work is in functional genomics and is focused on identifying genes and pathways affected by genetic associations for cardio metabolic traits. Her role includes writing, tailoring and documenting pipelines to perform data quality control, run analyses and visualise results.

Her previous research includes a theoretical study of the MYCN enigma in neuroblastoma (a paediatric cancer), where she created a mathematical model (using ordinary differential equations) of the signal pathway MYCN/ARF/MDM2/P53. Before joining NDPH in 2022, she collected COVID19 data for the University of Oxford and the Office for National Statistics (ONS).

She has a bachelor’s degree in applied mathematics and a master’s degree in computational medicine.